AngioDynamics Inc (ANGO)
6.83
-0.12
(-1.73%)
USD |
NASDAQ |
Nov 22, 16:00
6.83
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Cash from Financing (Quarterly): -0.509M for Aug. 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -0.509M |
| May 31, 2024 | -5.00M |
| February 29, 2024 | 0.694M |
| November 30, 2023 | -0.352M |
| August 31, 2023 | -59.59M |
| May 31, 2023 | 0.00 |
| February 28, 2023 | 0.941M |
| November 30, 2022 | 0.103M |
| August 31, 2022 | 24.38M |
| May 31, 2022 | 0.329M |
| February 28, 2022 | 0.966M |
| November 30, 2021 | 0.942M |
| August 31, 2021 | 5.446M |
| May 31, 2021 | -9.445M |
| February 28, 2021 | -8.022M |
| November 30, 2020 | -0.01M |
| August 31, 2020 | 0.491M |
| May 31, 2020 | 24.95M |
| February 29, 2020 | 15.56M |
| November 30, 2019 | 0.00 |
| August 31, 2019 | -135.75M |
| May 31, 2019 | -7.242M |
| February 28, 2019 | -10.08M |
| November 30, 2018 | 53.90M |
| August 31, 2018 | -2.645M |
| Date | Value |
|---|---|
| May 31, 2018 | -0.861M |
| February 28, 2018 | -0.428M |
| November 30, 2017 | -7.724M |
| August 31, 2017 | -2.538M |
| May 31, 2017 | -6.567M |
| February 28, 2017 | -14.01M |
| November 30, 2016 | -15.60M |
| August 31, 2016 | -1.797M |
| May 31, 2016 | -4.496M |
| February 29, 2016 | -6.797M |
| November 30, 2015 | -10.30M |
| August 31, 2015 | -2.071M |
| May 31, 2015 | -11.11M |
| February 28, 2015 | -2.74M |
| November 30, 2014 | 5.772M |
| August 31, 2014 | -2.391M |
| May 31, 2014 | 2.64M |
| February 28, 2014 | -5.472M |
| November 30, 2013 | -10.91M |
| August 31, 2013 | -0.272M |
| May 31, 2013 | -1.757M |
| February 28, 2013 | -1.255M |
| November 30, 2012 | -1.978M |
| August 31, 2012 | -1.296M |
| May 31, 2012 | 141.34M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-59.59M
Minimum
Aug 2023
24.95M
Maximum
May 2020
-0.4067M
Average
0.216M
Median
Cash from Financing (Quarterly) Benchmarks
| Globus Medical Inc | 19.58M |
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.25M |
| Cash from Investing (Quarterly) | -2.405M |
| Free Cash Flow | -26.58M |
| Free Cash Flow Per Share (Quarterly) | -0.4759 |
| Free Cash Flow to Equity (Quarterly) | -19.42M |
| Free Cash Flow to Firm (Quarterly) | -19.34M |
| Free Cash Flow Yield | -9.64% |